View DividendAedes 경영진경영진 기준 점검 0/4현재 CEO에 대한 정보가 충분하지 않습니다.핵심 정보Giorgio Ferrari최고경영자n/a총 보수CEO 급여 비율n/aCEO 재임 기간2.4yrsCEO 지분 보유율n/a경영진 평균 재임 기간데이터 없음이사회 평균 재임 기간2.4yrs최근 경영진 업데이트공시 • Mar 25Aedes Spa, Annual General Meeting, Apr 24, 2026Aedes Spa, Annual General Meeting, Apr 24, 2026, at 15:00 W. Europe Standard Time.Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Stella D'Atri was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Stella D'Atri was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.모든 업데이트 보기Recent updatesNew Risk • May 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 300% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.3% operating cash flow to total debt). Shareholders have been substantially diluted in the past year (300% increase in shares outstanding). Revenue is less than US$1m (€791k revenue, or US$921k). Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€9.99m market cap, or US$11.6m).Buy Or Sell Opportunity • May 25Now 97% overvalued after recent price riseOver the last 90 days, the stock has risen 957% to €0.78. The fair value is estimated to be €0.40, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 95% over the last 3 years. Meanwhile, the company has become profitable.공시 • Mar 25Aedes Spa, Annual General Meeting, Apr 24, 2026Aedes Spa, Annual General Meeting, Apr 24, 2026, at 15:00 W. Europe Standard Time.Reported Earnings • Mar 24Full year 2025 earnings releasedFull year 2025 results: Revenue: €929.4k (up €780.4k from FY 2024). Net income: €264.2k (up €1.75m from FY 2024). Profit margin: 28% (up from net loss in FY 2024).공시 • Feb 25Aedes Spa has completed a Follow-on Equity Offering in the amount of €4.993698 million.Aedes Spa has completed a Follow-on Equity Offering in the amount of €4.993698 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 93,315,543 Price\Range: €0.052 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,717,112 Price\Range: €0.052 Transaction Features: Rights OfferingNew Risk • Jan 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (36% accrual ratio). Revenue is less than US$1m (€587k revenue, or US$701k). Market cap is less than US$10m (€3.04m market cap, or US$3.63m).New Risk • Oct 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (€149k revenue, or US$173k). Market cap is less than US$10m (€6.59m market cap, or US$7.66m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).New Risk • Dec 30New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (€5.19m market cap, or US$5.41m). Minor Risk Share price has been volatile over the past 3 months (5.9% average weekly change).Reported Earnings • Jul 30First half 2023 earnings released: €0.025 loss per share (vs €0.003 loss in 1H 2022)First half 2023 results: €0.025 loss per share (further deteriorated from €0.003 loss in 1H 2022). Net loss: €790.0k (loss widened €702.0k from 1H 2022).New Risk • Feb 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 59% per year over the past 5 years. Revenue is less than US$1m (€50k revenue, or US$54k). Market cap is less than US$10m (€6.37m market cap, or US$6.90m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).New Risk • Jun 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (€6.59m market cap, or US$7.19m). Minor Risks Share price has been volatile over the past 3 months (4.9% average weekly change). Revenue is less than US$5m (€1.1m revenue, or US$1.2m).Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Stella D'Atri was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Stella D'Atri was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 28Full year 2020 earnings releasedThe company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: €8.98m (up 4.0% from FY 2019). Net loss: €1.78m (down €1.85m from profit in FY 2019).Is New 90 Day High Low • Feb 19New 90-day low: €0.40The company is down 20% from its price of €0.50 on 20 November 2020. The Italian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 6.0% over the same period.Is New 90 Day High Low • Jan 30New 90-day low: €0.42The company is down 13% from its price of €0.48 on 30 October 2020. The Italian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 4.0% over the same period.Is New 90 Day High Low • Jan 13New 90-day low: €0.45The company is down 12% from its price of €0.52 on 15 October 2020. The Italian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is down 2.0% over the same period.분석 기사 • Jan 05Are Restart SIIQ S.p.A.'s (BIT:RST) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?With its stock down 13% over the past three months, it is easy to disregard Restart SIIQ (BIT:RST). However, the...Is New 90 Day High Low • Dec 28New 90-day low: €0.46The company is down 12% from its price of €0.52 on 29 September 2020. The Italian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 1.0% over the same period.Is New 90 Day High Low • Dec 12New 90-day low: €0.48The company is down 14% from its price of €0.56 on 11 September 2020. The Italian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is flat over the same period.Is New 90 Day High Low • Nov 06New 90-day low: €0.48The company is down 8.0% from its price of €0.52 on 07 August 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 2.0% over the same period.Is New 90 Day High Low • Oct 21New 90-day low: €0.49The company is down 13% from its price of €0.57 on 22 July 2020. The Italian market is down 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is flat over the same period.공시 • Oct 03Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) acquired Viale Richard 5 for €12 million.Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) acquired Viale Richard 5 for €12 million on October 1, 2020. Invel has identified a comprehensive capex programme that will see it invest €16 million to realize the asset’s potential to deliver value. This latest acquisition brings the investment firm’s AUM in Italy to approximately €850 million. Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) completed the acquisition of Viale Richard 5 on October 1, 2020.CEOGiorgio Ferrari (32 yo)2.4yrs재임 기간Giorgio Ferrari is Chief Executive Officer of Aedes Spa (formerly known as Restart SIIQ S.p.A.) since 2024 and serves as its Director from March 2024.이사회 구성원이름직위재임 기간보수지분Giorgio FerrariCEO & Director2.3yrs데이터 없음데이터 없음Federico StradaPresident of the Board2.4yrs데이터 없음데이터 없음Lucia TacchinoDirector2.4yrs데이터 없음데이터 없음Serena LungoDirector2.4yrs데이터 없음데이터 없음Marco CentoreDirector2.4yrs데이터 없음데이터 없음Marco PedrettiDirector2.4yrs데이터 없음데이터 없음Elena Olga RipamontiDirectorno data데이터 없음데이터 없음더 보기2.4yrs평균 재임 기간경험이 풍부한 이사회: AEDES의 이사회는 경험이 부족한 것으로 간주됩니다(평균 재임 2.4 년) — 신규 이사회일 가능성이 있습니다.View Ownership기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/09 07:57종가2026/06/09 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Aedes Spa는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Federico PezzettiIntermonte SIM S.p.A.
공시 • Mar 25Aedes Spa, Annual General Meeting, Apr 24, 2026Aedes Spa, Annual General Meeting, Apr 24, 2026, at 15:00 W. Europe Standard Time.
Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Stella D'Atri was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Stella D'Atri was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
New Risk • May 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 300% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.3% operating cash flow to total debt). Shareholders have been substantially diluted in the past year (300% increase in shares outstanding). Revenue is less than US$1m (€791k revenue, or US$921k). Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (€9.99m market cap, or US$11.6m).
Buy Or Sell Opportunity • May 25Now 97% overvalued after recent price riseOver the last 90 days, the stock has risen 957% to €0.78. The fair value is estimated to be €0.40, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 95% over the last 3 years. Meanwhile, the company has become profitable.
공시 • Mar 25Aedes Spa, Annual General Meeting, Apr 24, 2026Aedes Spa, Annual General Meeting, Apr 24, 2026, at 15:00 W. Europe Standard Time.
Reported Earnings • Mar 24Full year 2025 earnings releasedFull year 2025 results: Revenue: €929.4k (up €780.4k from FY 2024). Net income: €264.2k (up €1.75m from FY 2024). Profit margin: 28% (up from net loss in FY 2024).
공시 • Feb 25Aedes Spa has completed a Follow-on Equity Offering in the amount of €4.993698 million.Aedes Spa has completed a Follow-on Equity Offering in the amount of €4.993698 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 93,315,543 Price\Range: €0.052 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,717,112 Price\Range: €0.052 Transaction Features: Rights Offering
New Risk • Jan 29New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Italian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (36% accrual ratio). Revenue is less than US$1m (€587k revenue, or US$701k). Market cap is less than US$10m (€3.04m market cap, or US$3.63m).
New Risk • Oct 24New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 23% per year over the past 5 years. Revenue is less than US$1m (€149k revenue, or US$173k). Market cap is less than US$10m (€6.59m market cap, or US$7.66m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end).
New Risk • Dec 30New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (€5.19m market cap, or US$5.41m). Minor Risk Share price has been volatile over the past 3 months (5.9% average weekly change).
Reported Earnings • Jul 30First half 2023 earnings released: €0.025 loss per share (vs €0.003 loss in 1H 2022)First half 2023 results: €0.025 loss per share (further deteriorated from €0.003 loss in 1H 2022). Net loss: €790.0k (loss widened €702.0k from 1H 2022).
New Risk • Feb 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 59% per year over the past 5 years. Revenue is less than US$1m (€50k revenue, or US$54k). Market cap is less than US$10m (€6.37m market cap, or US$6.90m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
New Risk • Jun 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 4.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (€6.59m market cap, or US$7.19m). Minor Risks Share price has been volatile over the past 3 months (4.9% average weekly change). Revenue is less than US$5m (€1.1m revenue, or US$1.2m).
Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Stella D'Atri was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Stella D'Atri was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 28Full year 2020 earnings releasedThe company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: €8.98m (up 4.0% from FY 2019). Net loss: €1.78m (down €1.85m from profit in FY 2019).
Is New 90 Day High Low • Feb 19New 90-day low: €0.40The company is down 20% from its price of €0.50 on 20 November 2020. The Italian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Jan 30New 90-day low: €0.42The company is down 13% from its price of €0.48 on 30 October 2020. The Italian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 4.0% over the same period.
Is New 90 Day High Low • Jan 13New 90-day low: €0.45The company is down 12% from its price of €0.52 on 15 October 2020. The Italian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is down 2.0% over the same period.
분석 기사 • Jan 05Are Restart SIIQ S.p.A.'s (BIT:RST) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?With its stock down 13% over the past three months, it is easy to disregard Restart SIIQ (BIT:RST). However, the...
Is New 90 Day High Low • Dec 28New 90-day low: €0.46The company is down 12% from its price of €0.52 on 29 September 2020. The Italian market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 1.0% over the same period.
Is New 90 Day High Low • Dec 12New 90-day low: €0.48The company is down 14% from its price of €0.56 on 11 September 2020. The Italian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is flat over the same period.
Is New 90 Day High Low • Nov 06New 90-day low: €0.48The company is down 8.0% from its price of €0.52 on 07 August 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 2.0% over the same period.
Is New 90 Day High Low • Oct 21New 90-day low: €0.49The company is down 13% from its price of €0.57 on 22 July 2020. The Italian market is down 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is flat over the same period.
공시 • Oct 03Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) acquired Viale Richard 5 for €12 million.Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) acquired Viale Richard 5 for €12 million on October 1, 2020. Invel has identified a comprehensive capex programme that will see it invest €16 million to realize the asset’s potential to deliver value. This latest acquisition brings the investment firm’s AUM in Italy to approximately €850 million. Invel Real Estate and an institutional investor from Restart SIIQ S.p.A. (BIT:RST) completed the acquisition of Viale Richard 5 on October 1, 2020.